Phase 2 data in type 2 diabetes showed CagriSema reduced HbA1c by 2.2 percentage points compared to 1.8 with semaglutide alone and 0.9 with cagrilintide alone, while achieving 15.6% weight loss versus 5.1% with semaglutide alone
[DOI] [PMC free article] [PubMed] [Google Scholar] 142.Afaq F., Adhami V.M., Ahmad N., Mukhtar H
2024 May 14;331(18):1519-1521
Strong indicators that you are ready for the next dose step include: GI side effects have fully resolved at the current dose Appetite suppression has stabilized (not increasing or decreasing week to week) Weight loss has slowed or plateaued at the current dose Energy levels are stable and consistent Sleep quality has returned to baseline Indicators that you should hold at the current dose for another cycle include: Persistent nausea beyond the first week at the current dose Digestive issues that have not resolved Weight loss is still progressing well (no need to increase if current dose is working) Energy levels are still adjusting Any concerning symptoms that need medical evaluation The tracking data also helps identify your optimal maintenance dose
By increasing the bodys ability to process fats, these injections help you burn calories more effectively, even when youre not exercising
When considering any supplement for the long term, safety is the first priority
